All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date | 2005-000690-22 | A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy | bad-data | |
Exempt | 2006-000868-83 | A Phase I/II Study of CP-4055 in Patients with Refractory/Relapsed Hematologic Malignancies | 2009-07-02 | not-yet-due |
Not reported | 2006-006766-41 | A phase II Clinical Study of CP-4055 as second line therapy in patients with advanced colorectal cancer | 2008-09-01 | due-trials |
Not reported | 2007-000915-28 | A multicentre, dose finding, phase II Study of CP-4055 in combination with Sorafenib in patients with metastatic malignant melanoma | 2008-08-25 | due-trials |
Completed, but no date | 2007-003323-20 | A Phase I/II Study of CP-4055 in Patients with Platinum Resistant Ovarian Cancer | bad-data | |
Ongoing | 2007-007476-42 | A phase II study of CP-4126 in patients with advanced pancreatic cancer | not-yet-due | |
Listed as ongoing, but also has a completion date | 2008-008518-38 | A Phase II Study of CP-4055 plus Idarubicin as Second Course Remission-Induction Therapy in Patients with Acute Myeloid Leukaemia | 2013-05-07 | bad-data |
Listed as ongoing, but also has a completion date | 2009-014445-80 | A Randomised Phase III Study of Elacytarabine vs. Investigator´s Choice in Patients with Late Stage Acute Myeloid Leukaemia Estudio aleatorizado fase III de elacitarabina comparada con la elección de... | 2013-05-17 | bad-data |